An EU-backed secure messaging service for telemedicine has been unveiled that is designed to form the backbone of a pan-European remote diagnosis system.
Licore's Web Correspondent is a browser-based interface running on NT and using 128-bit encryption to communicate information on specialist medical problems. Licore is one of several companies, sponsored by the EU, involved in the Medicate joint venture to create a telemedicine system.
PC Week witnessed a Medicate demonstration of how an asthma sufferer can breath into a device that measues symptoms, then upload the results to Web Correspondent via modem.
The information is transmitted to medical staff and specialists at any location via the Internet. Medics access the site to download figures and review or manipulate the data before issuing a preliminary remote diagnosis.
The main aim is to spare patients from having to make frequent hospital trips, but the system would also save on resources and paperwork.
Medicate intends to build a European telemedicine infrastructure so that a wide range of medical problems can be dealt with on a remote basis, Licore said.
Medicate will seek to sell the equipment and license the service to health authorities - including the NHS in the UK - by arguing that health care will be improved at the same time that consultant and hospital overheads are reduced.
The entire Medicate system is expected to be available in 18 months, Licore said.
Geoengineering on the sea floor near glaciers would form a new ice shelf to prevent melting
Alterations in capillary blood flow can be caused by body position change
Curiosity rover is in 'normal mode' but not transmitting scientific data back to base
NatWest outage comes a day after Barclays' IT systems shut out customers and staff